Array Biopharma Inc (NASDAQ:ARRY)

15.75
Delayed Data
As of May 18
 0.00 / 0.00%
Today’s Change
7.15
Today|||52-Week Range
18.78
+23.05%
Year-to-Date

Today’s Trading

Previous close15.75
Today’s open15.78
Day’s range15.64 - 16.09
Volume1,944,465
Average volume (3 months)3,354,535
Market cap$3.3B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)-10.77%
Earnings growth (this year)-2.99%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+9.41%
P/E ratioNM
Price/Sales9.06
Price/Book230.35

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.52+1.24%
MYOKMyoKardia Inc+1.20+2.37%
CBMCambrex Corp-0.20-0.42%
TBPHTheravance Biopharma...-0.17-0.69%
Data as of 4:02pm ET, 05/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$150.9M
Annual profit (last year)-$116.8M
Net profit margin-77.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts